Showing results (1171-1180 of 5,695) with videos related to

Sort By:
Pageof 570
Tumori|October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trialFilippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Tumori|July 11, 2022
Clinical application and prospect of MRD evaluation in lung cancer based on ctDNA level: A reviewXing Yan, Changhong Liu
Tumori|July 11, 2022
Central venous catheters-related-thrombosis and risk factors in oncological patients: A retrospective evaluation of recent risk scoresIda Taglialatela, Luigi Mariani, Katia Fiorella Dotti, et al.
Tumori|July 8, 2022
Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q dataLaura Sala, Stefano Bonomi, Chiara Maura Ciniselli, et al.
Tumori|June 16, 2022
A homogeneous treatment for non-DIPG diffuse midline gliomaElisabetta Schiavello, Veronica Biassoni, Giovanna Gattuso, et al.
Tumori|May 27, 2021
Prognostic role of standard uptake value according to pathologic features of lung adenocarcinomaPietro Bertoglio, Luigi Ventura, Vittorio Aprile, et al.
Tumori|February 8, 2020
Anlotinib in treatment of an elderly patient with recurrent advanced SCLCYing Zhang, Beili Jia, Jing Li, et al.
Tumori|May 17, 2022
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot studySophie Deneuve, Thierry Bastogne, Mirlande Duclos, et al.
Tumori|July 23, 2021
Efficacy of lenvatinib plus pembrolizumab in hepatocellular carcinoma with metachronous lung metastasis: a report of two casesJieLang Li, Ting Chen, Feng Bi, et al.
Tumori|July 23, 2021
Efficacy and safety of induction chemotherapy with daunorubicin or idarubicin in the treatment of an adult with acute lymphoblastic leukemiaQi Zhang, Chun-Hong Zhang, Zhen-Dong Wang, et al.
Pageof 570